The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function-Reference-Cited by-同舟云学术

The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function

Published:2018-04-19 Issue:7 Volume:84 Page:1535-1543
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Golding John F.¹,Wesnes Keith A.²³,Leaker Brian R.⁴

Affiliation:

1. Department of Psychology, Faculty of Science & Technology; University of Westminster; London UK

2. Medical School; University of Exeter; Exeter UK

3. Wesnes Cognition Ltd; Streatley-on-Thames UK

4. Nephro-Urology Clinical Trials Ltd.; London UK

Funder

Pfizer UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13579/fullpdf

Reference43 articles.

1. Antimotion sickness and antiemetic drugs;Wood;Drugs,1979

2. Muscarinic receptor subtypes;Hulme;Ann Rev Pharmacol Toxicol,1990

3. Time-course of effects of oral cinnarizine and hyoscine on task performance;Golding;J Psychopharmacol,1989

4. Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task;Wesnes;Neuropsychobiology,1983

5. Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects;Parrott;Psychopharmacology (Berl),1987

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the cognitive safety of antimuscarinics in the treatment of overactive bladder;Expert Opinion on Drug Safety;2024-09-10

2. Scopolamine for patients with motion sickness: a systematic review and meta-analysis with trial sequential analysis;Acta Oto-Laryngologica;2024-09-03

3. An assessment of the effects of neurokinin₁ receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development;British Journal of Clinical Pharmacology;2023-08-17

4. Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis;Alimentary Pharmacology & Therapeutics;2023-03-14

5. Nutritional and Behavioral Countermeasures as Medication Approaches to Relieve Motion Sickness: A Comprehensive Review;Nutrients;2023-03-07